Microbot Medical Inc. financial data

Symbol
MBOT on Nasdaq
Location
Hingham, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1499% % 326%
Debt-to-equity 7.6% % -80%
Return On Equity -37% % 83%
Return On Assets -34% % 78%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 67,158,044 shares 297%
Common Stock, Shares, Outstanding 65,833,556 shares 295%
Entity Public Float $15,900,000 USD -58%
Common Stock, Value, Issued $659,000 USD 292%
Weighted Average Number of Shares Outstanding, Basic 48,095,384 shares 192%
Weighted Average Number of Shares Outstanding, Diluted 48,095,384 shares 192%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $6,725,000 USD 16%
General and Administrative Expense $7,310,000 USD 63%
Operating Income (Loss) $14,035,000 USD -37%
Net Income (Loss) Attributable to Parent $13,070,000 USD -17%
Earnings Per Share, Basic 0 USD/shares 43%
Earnings Per Share, Diluted 0 USD/shares 43%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $6,704,000 USD 1300%
Marketable Securities, Current $73,454,000 USD 1803%
Cash, Cash Equivalents, and Short-term Investments $80,158,000 USD 1748%
Assets, Current $80,785,000 USD 1517%
Property, Plant and Equipment, Net $78,000 USD -21%
Operating Lease, Right-of-Use Asset $897,000 USD 687%
Assets $81,760,000 USD 1470%
Accounts Payable, Current $509,000 USD 107%
Employee-related Liabilities, Current $1,409,000 USD 94%
Accrued Liabilities, Current $2,128,000 USD 101%
Liabilities, Current $2,934,000 USD 114%
Operating Lease, Liability, Noncurrent $602,000 USD 1976%
Liabilities $3,536,000 USD 153%
Retained Earnings (Accumulated Deficit) $100,622,000 USD -15%
Stockholders' Equity Attributable to Parent $78,224,000 USD 1954%
Liabilities and Equity $81,760,000 USD 1470%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,874,000 USD -19%
Net Cash Provided by (Used in) Financing Activities $27,806,000 USD 1060%
Net Cash Provided by (Used in) Investing Activities $24,830,000 USD -1834%
Common Stock, Shares Authorized 120,000,000 shares 100%
Common Stock, Shares, Issued 65,833,556 shares 295%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $102,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6,758,000 USD 1182%
Interest Paid, Excluding Capitalized Interest, Operating Activities $40,000 USD 14%
Deferred Tax Assets, Valuation Allowance $118,374,000 USD 2%
Deferred Tax Assets, Gross $118,404,000 USD 1.7%
Operating Lease, Liability $899,000 USD
Payments to Acquire Property, Plant, and Equipment $13,000 USD -7.1%
Lessee, Operating Lease, Liability, to be Paid $1,044,000 USD
Property, Plant and Equipment, Gross $664,000 USD 3.9%
Operating Lease, Liability, Current $297,000 USD 357%
Lessee, Operating Lease, Liability, to be Paid, Year Two $247,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $298,000 USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $145,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $229,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $118,309,000 USD 2.2%
Preferred Stock, Shares Authorized 1,000,000 shares
Lessee, Operating Lease, Liability, to be Paid, Year Four $189,000 USD
Depreciation, Depletion and Amortization $15,000 USD -46%
Deferred Tax Assets, Net of Valuation Allowance $30,000 USD -92%